In preliminary recommendations published today (8 February) NICE is asking Allergan for more information on its product dexamethasone (Ozurdex) intravitreal implant, for the treatment of macular oedema secondary to retinal vein occlusion (RVO). The m…
How to Diagnose Macular Degeneration
Making the diagnosis of macular degeneration is based upon your age, appearance and vision. It really doesn’t matter if your parents have it.
Medical interventions for traumatic hyphema
Background
Traumatic hyphema is the entry of blood into the anterior chamber (the space between the cornea and iris) subsequent to a blow or a projectile striking the eye. Hyphema uncommonly causes permanent loss of vision. Associated trauma (e.g., co…
Steroids for traumatic optic neuropathy
Background
Traumatic optic neuropathy (TON) is an important cause of severe visual loss following blunt or penetrating head trauma. Following the initial injury, optic nerve swelling within the optic nerve canal can result in secondary retinal ganglio…
Bio-Retina, An Artificial Minimally Invasive Retinal Prosthesis
CSEM (Centre Suisse d’Electronique et de Microtechnique) has joined Israel’s Rainbow Medical and Zyvex Labs in their Nano Retina joint venture to develope a retinal prosthesis. The tiny Bio-Retina would be implanted in a minimally invasive procedure and the development team believes that return of sight would be immediate, save for a week of traditional post procedure recovery.
NICE Consults On Dexamethasone Intravitreal Implant For The Treatment Of Macular Oedema Secondary To Retinal Vein Occlusion
In preliminary recommendations published today (8 February) NICE is asking Allergan for more information on its product dexamethasone (Ozurdex) intravitreal implant, for the treatment of macular oedema secondary to retinal vein occlusion (RVO). The mac…